Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 1
1963 4
1964 2
1965 2
1966 5
1967 3
1968 6
1969 1
1971 5
1973 1
1974 2
1981 1
1982 1
1983 2
1984 2
1985 5
1986 3
1987 4
1988 3
1989 3
1990 4
1991 1
1992 7
1994 9
1995 10
1996 20
1997 23
1998 21
1999 22
2000 27
2001 18
2002 20
2003 24
2004 29
2005 34
2006 21
2007 23
2008 16
2009 10
2010 8
2011 13
2012 23
2013 29
2014 18
2015 32
2016 24
2017 32
2018 38
2019 41
2020 50
2021 46
2022 43
2023 40
2024 51
2025 61
2026 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

901 results

Results by year

Filters applied: . Clear all
Page 1
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy.
Noh MH, Kang JM, Miller AA, Nguyen G, Huang M, Shim JS, Bueso-Perez AJ, Murphy SA, Rivera-Caraballo KA, Otani Y, Kim E, Yoo SH, Yan Y, Banasavadi-Siddegowda Y, Nakashima H, Chiocca EA, Kaur B, Zhao Z, Lee TJ, Yoo JY. Noh MH, et al. Among authors: otani y. Neuro Oncol. 2024 Sep 5;26(9):1602-1616. doi: 10.1093/neuonc/noae105. Neuro Oncol. 2024. PMID: 38853689 Free PMC article. Clinical Trial.
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MP, O'Rourke DM, Mohan S, Davatzikos C; ReSPOND consortium. Akbari H, et al. Among authors: otani y. Neuro Oncol. 2025 May 15;27(4):1102-1115. doi: 10.1093/neuonc/noae260. Neuro Oncol. 2025. PMID: 39665363 Free PMC article.
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Shiraki M, Kadowaki S, Miwa Y, Nishimura K, Maruyama Y, Kishida D, Imagawa K, Kobayashi C, Takada H, Mitsunaga K, Inoue Y, Ebato T, Miyamoto T, Hiejima E, Sato S, Migita K, Matsubayashi T, Kobayashi D, Hasegawa E, Kaneko U, Ishikawa T, Onodera M, Matsushita K, Koike Y, Umebayashi H, Kakuta F, Abukawa D, Funakoshi Y, Ishimura M, Otani Y, Nishizawa T, Ishige T, Hatori R, Tanaka S, Kusunoki S, Nakamura K, Shirai H, Hatai Y, Miyaoka F, Kaneko S, Shimbo A, Shimizu M, Kanegane H, Hashimoto M, Negoro N, Yoshida T, Wada Y, Usami M, Wada T, Izawa K, Yasumi T, Nishikomori R, Ohnishi H. Shiraki M, et al. Among authors: otani y. Front Immunol. 2025 Jun 12;16:1548042. doi: 10.3389/fimmu.2025.1548042. eCollection 2025. Front Immunol. 2025. PMID: 40574834 Free PMC article.
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy.
Otani Y, Yoo JY, Lewis CT, Chao S, Swanner J, Shimizu T, Kang JM, Murphy SA, Rivera-Caraballo K, Hong B, Glorioso JC, Nakashima H, Lawler SE, Banasavadi-Siddegowda Y, Heiss JD, Yan Y, Pei G, Caligiuri MA, Zhao Z, Chiocca EA, Yu J, Kaur B. Otani Y, et al. Clin Cancer Res. 2022 Apr 1;28(7):1460-1473. doi: 10.1158/1078-0432.CCR-21-2347. Clin Cancer Res. 2022. PMID: 35022322 Free PMC article. Clinical Trial.
The 2024 magnonics roadmap.
Flebus B, Grundler D, Rana B, Otani Y, Barsukov I, Barman A, Gubbiotti G, Landeros P, Akerman J, Ebels U, Pirro P, Demidov VE, Schultheiss K, Csaba G, Wang Q, Ciubotaru F, Nikonov DE, Che P, Hertel R, Ono T, Afanasiev D, Mentink J, Rasing T, Hillebrands B, Kusminskiy SV, Zhang W, Du CR, Finco A, van der Sar T, Luo YK, Shiota Y, Sklenar J, Yu T, Rao J. Flebus B, et al. Among authors: otani y. J Phys Condens Matter. 2024 Jun 14;36(36). doi: 10.1088/1361-648X/ad399c. J Phys Condens Matter. 2024. PMID: 38565125 Review.
Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma.
Matsuoka A, Shien K, Tomida S, Ohki M, Hisamatsu K, Fujiwara R, Ishimura K, Fujii R, Higashihara T, Hayashi N, Okada K, Yoshichika R, Mukohara F, Yoshikawa M, Fukumoto Y, Suzawa K, Tomioka Y, Tanaka S, Miyoshi K, Okazaki M, Sugimoto S, Otani Y, Tanaka A, Inoue H, Togashi Y, Yamamoto H, Ennishi D, Toyooka S. Matsuoka A, et al. Among authors: otani y. Commun Biol. 2025 Dec 16;8(1):1773. doi: 10.1038/s42003-025-09162-w. Commun Biol. 2025. PMID: 41402584 Free PMC article.
Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT).
Fujimoto T, Yamasaki O, Kanehira N, Matsushita H, Sakurai Y, Kenmotsu N, Mizuta R, Kondo N, Takata T, Kitamatsu M, Igawa K, Fujimura A, Otani Y, Shirakawa M, Shigeyasu K, Teraishi F, Togashi Y, Suzuki M, Fujiwara T, Michiue H. Fujimoto T, et al. Among authors: otani y. Cancer Sci. 2024 Oct;115(10):3231-3247. doi: 10.1111/cas.16298. Epub 2024 Aug 9. Cancer Sci. 2024. PMID: 39119813 Free PMC article.
901 results